Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

99 Cent Urinalysis App Raises Questions About mHealth Standards

This article was originally published in The Gray Sheet

Executive Summary

The uChek urinalysis app made a splash last month with its launch in the iTunes App Store, but it did not appear to follow the same pre-market requirements as analogous conventional urine analyzers, contributing to questions about mobile health regulatory oversight and innovation.

You may also be interested in...



Eight Things That Will Fix Medtech Investing

The last five years have been brutal ones for medical device VCs and entrepreneurs, yet there’s still cause for hope. In a series of interviews, we asked venture capitalists, entrepreneurs, and executives: what gives you hope and what makes you optimistic about the future of medtech?

Digital Health Regulation Debate Continues At mHealth Summit

Federal officials took pains at this year’s mHealth Summit in Washington, D.C., to describe their excitement for the digital health field and their plans to minimize the “touch” of federal regulation. But it was also clear at the meeting that a significant component of the health information technology space still looks skeptically at FDA and its long-term intentions.

Digital Health Briefs: ONC Chief Leaves, Interoperability Standards, Verizon 510(k)

HHS Office of the National Coordinator for Health IT director departs. FDA accepts new interoperability standards. Verizon Health gains clearance for data device. Meta-analysis finds mixed results for self-monitoring blood pressure. Biosense pursues CE mark funding for uChek. Nanoengineers create sweat-monitoring tattoo.

Related Content

Topics

UsernamePublicRestriction

Register

MT032066

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel